AMC SCIENCES
AMC Sciences is committed to the exploration and development of
innovative therapeutics to treat unmet needs of patients.
Incorporated as a subsidiary of HD Hyundai, AMC Sciences will develop innovative
therapeutics through open innovation and in collaboration with one of the world’s
most respected hospital, Asan Medical Center
Advancing hospital-based new drug development.
AMC Sciences is committed to the exploration and development of innovative therapeutics to treat unmet needs of patients.
Incorporated as a subsidiary of HD Hyundai, AMC Sciences will develop innovative therapeutics through open innovation and in collaboration with one of the world’s most respected hospital, Asan Medical Center.
AMC Sciences
Platform
Technology
-
-
AMC Sciences has a ProteoXplore platform that discovers new targets for intractable diseases based on vast patient tissues and clinical information held by Asan Medical Center. The platform presents the most effective drug targets by integrated analysis of patients' genomes, transcriptomes, protein body information, and medical records.
Business Model
-
Central Lab
Exploring and validating new drug technologies
-
Prototype Company
Operates as an internal organization (CIC) and supports early asset development
-
Company Spin-off
AMC Sciences-led Planning Start-up
Portfolio
AMC Sciences is developing innovative therapeutic technologies for cancer, immune diseases, eye diseases, and more, and fostering early-stage prototype companies focusing on each field.
Central Lab
AMC Sciences has its own laboratory that introduces, evaluates, and develops promising technologies and employs talented people who are passionate about developing innovative new drugs.
If you want to do it with AMC Sciences?
AMC Sciences is hiring talented people who are passionate about developing new drugs.
Career